0001299130-22-000114.txt : 20221003 0001299130-22-000114.hdr.sgml : 20221003 20221003082202 ACCESSION NUMBER: 0001299130-22-000114 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220929 FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Susan G. CENTRAL INDEX KEY: 0001825421 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 221286063 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2022-09-29 0001299130 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB 0001825421 Kim Susan G. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 1305 O'BRIEN DRIVE MENLO PARK CA 94025 0 1 0 0 See Remarks Common Stock 2022-09-29 4 S 0 12968 5.614 D 163488 D Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale price represents the weighted average sale price of the shares sold ranging from $5.41 to $5.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Includes 1,490 shares purchased on September 1, 2021, March 1, 2022 and September 1, 2022 under the Company's 2010 Employee Stock Purchase Plan. Chief Financial Officer /s/ Michele Farmer, Attorney-in-fact 2022-10-03